Cite

    Nandanwar, M. et al. (2022). Preclinical safety evaluation of levonadifloxacin, a novel anti‐methicillin‐resistant Staphyloccocus aureus benzoquinolizine fluoroquinolone by intravenous and oral administration. Journal of applied toxicology. 42 (8), pp. 1354-1370. [Online].